Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia

Schizophrenia Research

Volumn 67, Issue 1, 2004, Pages 53-62

  Abdolmaleky, Hamid Mostafavi ^a,b,c   Faraone, Stephen V ^a,b,d   Glatt, Stephen J ^a,b   Tsuang, Ming T ^a,b,d,e,f  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^b Harvard Inst Psychiat E   (United States)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e Psychiatry Service   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

5HT2a receptor; Meta analysis; T102C polymorphism

Indexed keywords

SEROTONIN 2A RECEPTOR;

ALLELE; ARTICLE; CHROMOSOME 13; DNA METHYLATION; FAMILY STUDY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENOTYPE; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 1642483062     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00183-X     Document Type: Article

References (67)

1. Araga U.S., Narasu M.L. Association between the 102T/C polymorphism of serotonin-2A receptor gene and schizophrenia among south Indians. Mol. Psychiatry. 7:2002;540-541.
2. Arias B., Gasto C., Catalan R., Gutierrez B., Pintor L., Fananas L. The 5-HT(2A) receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients. Am. J. Med. Genet. 105:2001;801-804.
3. Arias B., Gutierrez B., Pintor L., Gasto C., Fananas L. Variability in the 5-HT(2A) receptor gene is associated with seasonal pattern in major depression. Mol. Psychiatry. 6:2001;239-242.
4. 2A receptor and clinical response to clozapine. Neurosci. Lett. 217:1996;177-178.
5. Attwood J.T., Yung R.L., Richardson B.C. DNA methylation and the regulation of gene transcription. Cell. Mol. Life Sci. 59:2002;241-257.
6. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry. 7:2002;405-411.
7. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16:2002;6-21.
8. Bondy B., Kuznik J., Baghai T., Schule C.P.Z., Minov C.et al. Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am. J. Med. Genet. 96:2000;831-835.
9. Bunzel R., Blumcke I., Cichon S., Normann S., Schramm J., Propping P., Nothen M.M. Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain. Brain Res., Mol. Brain Res. 59:1998;90-92.
10. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22:1999;231-238.
11. Chen C.H., Lee Y.R., Wei F.C., Koong F.J., Hwu H.G., Hsiao K.J. Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese. Psychiatr. Genet. 7:1997;35-38.
12. Chen R.Y., Sham P., Chen E.Y., Li T., Cheung E.F., Hui T.C., Kwok C.L., Lieh-Mak F., Zhao J.H., Collier D., Murray R. No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res. 105:2001;175-185.
13. Chen Y., Sharma R.P., Costa R.H., Costa E., Grayson D.R. On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 30:2002;2930-2939.
14. Clifford C.P., Nunez D.J. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1830.
15. Cooper D.N., Youssoufian H. The CpG dinucleotide and human genetic disease. Hum. Genet. 78:1988;151-155.
16. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials. 7:1986;177-188.
17. Du L., Faludi G., Palkovits M., Bakish D., Hrdina P.D. Serotonergic genes and suicidality. Crisis. 22:2001;54-60.
18. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:1997;629-634.
19. Erdmann J., Shimron-Abarbanell D., Rietschel M., Albus M., Maier W., Korner J., Bondy B., Chen K., Shih J.C., Knapp M., Propping P., Nothen M.M. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum. Genet. 97:1996;614-619.
20. Golimbet V.E., Manandian K.K., Abramova L.I., Orlova V.A., Kaleda V.G., Oleichik I.V., Iurov Iu B., Trubnikov V.I. Serotonin receptor gene allele polymorphism (5HTR2A) and clinical pathogenetic characteristics in patients with schizophrenia and schizophrenia spectrum disorders. Z. Nevropathol. Psihiatr. S.S. Korsakova. 100:2000;36-39.
21. Golimbet V.E., Alfimova M.V., Manandyan K.K., Mitushina N.G., Abramova L.I., Kaleda V.G., Oleichik I.V., Yurov Y., Trubnikov V.I. 5HTR2A gene polymorphism and personality traits in patients with major psychoses. Eur. Psychiatr. 17:2002;24-28.
22. Gross-Isseroff R., Israeli M., Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch. Gen. Psychiatry. 46:1989;237-241.
23. Hawi Z., Myakishev M.V., Straub R.E., O'Neill A., Kendler K.S., Walsh D., Gill M. No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families. Am. J. Med. Genet. (Neuropsychiat. Genet.). 74:1997;370-373.
24. He L., Li T., Melville C., Liu S., Feng G.Y., Gu N.F., Fox H., Shaw D., Breen G., Liu X., Sham P., Brown J., Collier D., St. Clair D. 102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. Am. J. Med. Genet. 88:1999;95-98.
25. Holmes C., Arranz M.J., Powell J.F., Collier D.A., Lovestone S. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum. Mol. Genet. 7:1998;1507-1509.
26. Huang Y., Liu X., Li T., Guo L., Sun X., Xiao X., Ma X., Wang Y., Collier D.A. Cases-Control association study and transmission disequilibrium test of T102C polymorphism in 5HT2A and Tourette syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 18:2001;11-13.
27. Hwu H.G., Chen C.H. Association of 5HT2A receptor gene polymorphism and alcohol abuse with behavior problems. Am. J. Med. Genet. 96:2000;797-800.
28. Inayama Y., Yoneda H., Sakai T., Ishida T., Nonomura Y., Kono Y., Takahata R., Koh J., Sakai J., Takai A., Inada Y., Asaba H. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am. J. Med. Genet. 67:1996;103-105.
29. Ishigaki T., Xie D.W., Liu J.C., Nakamura Y., Zhang H.Y., Tani K., Shimazu Y., Chen K., Shih J.C., Miyasato K., Ohara K. Intact 5-HT2A receptor exons and the adjoining intron regions in schizophrenia. Neuropsychopharmacology. 14:1996;339-347.
30. Jonsson E., Nothen M.M., Bunzel R., Propping P., Sedvall G. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1831.
31. Joober R., Benkelfat C., Brisebois K., Toulouse A., Turecki G., Lal S., Bloom D., Labelle A., Lalonde P., Fortin D., Alda M., Palmour R., Rouleau G.A. T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J. Psychiatry Neurosci. 24:1999;141-146.
32. Kim Y.K., Lee M.S., Kwak D.I. No association between schizophrenia and serotonin receptor type 2A gene in Korea. Psychiatr. Genet. 9:1999;47-49.
33. Knapp M., Seuchter S.A., Baur M.P. The haplotype-relative-risk (HRR) method for analysis of association in nuclear families. Am. J. Hum. Genet. 52:1993;1085-1093.
34. Lewis C.M. Genetic association studies: design, analysis and interpretation. Brief Bioinform. 3:2002;146-153.
35. Lin C.H., Tsai S.J., Yu Y.W., Song H.L., Tu P.C., Sim C.B., Hsu C.P., Yang K.H., Hong C.J. No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population. NeuroReport. 10:1999;57-60.
36. Liolitsa D., Powell J.F., Prince M., Lovestone S. Association study of the 5-HT(2A) receptor gene polymorphism, T102C and essential hypertension. J. Hum. Hypertens. 15:2001;335-339.
37. Malhotra A.K., Goldman D., Buchanan R., Breier A., Pickar D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1830-1831.
38. Nacmias B., Ricca V., Tedde A., Mezzani B., Rotella C.M., Sorbi S. 5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa. Neurosci. Lett. 277:1999;134-136.
39. Ngo V., Gourdji D., Laverriere J.N. Site-specific methylation of the rat prolactin and growth hormone promoters correlates with gene expression. Mol. Cell. Biol. 16:1996;3245-3254.
40. Nimgaonkar V.L., Zhang X.R., Brar J.S., DeLeo M., Ganguli R. 5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected. Psychiatr. Genet. 6:1996;23-27.
41. Nocjar C., Roth B.L., Pehek E.A. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience. 111:2002;163-176.
42. Ohara K., Nagai M., Tani K., Tsukamoto T. Schizophrenia and the serotonin-2A receptor promoter polymorphism. Psychiatry Res. 85:1999;221-224.
43. Orwin R.G., Cordray D.S. Effects of deficient reporting on meta-analysis: a conceptual framework and reanalysis. Psychol. Bull. 97:1985;134-147.
44. Pandey G.N. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann. N.Y. Acad. Sci. 836:1997;182-200.
45. Petronis A. The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology. 23:2000;1-12.
46. Polesskaya O.O., Sokolov B.P. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 67:2002;812-822.
47. Saddock B., Saddock V. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. vol. 1:2000;Lippincott Williams & Wilkins, Philadelphia.
48. Sasaki T., Hattori M., Fukuda R., Kunugi H., Nanko S. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1832.
49. Segman R.H., Heresco-Levy U., Finkel B., Goltser T., Shalem R., Schlafman M., Dorevitch A., Yakir A., Greenberg D., Lerner A., Lerer B. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol. Psychiatry. 6:2001;225-229.
50. Semwal P., Prasad S., Bhatia T., Deshpande S.N., Wood J., Nimgaonkar V.L., Thelma B.K. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Mol. Psychiatry. 6:2001;220-224.
51. Serretti A., Cusin C., Lorenzi C., Lattuada E., Lilli R., Smeraldi E. Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia. Am. J. Med. Genet. 96:2000;84-87.
52. Shinkai T., Ohmori O., Kojima H., Terao T., Suzuki T., Abe K. Negative association between T102C polymorphism of the 5-HT2a receptor gene and schizophrenia in Japan. Hum. Hered. 48:1998;212-215.
53. Singal R., Ginder G.D. DNA methylation. Blood. 93:1999;4059-4070.
54. Spurlock G., Heils A., Holmans P., Williams J., D'Souza U.M., Cardno A., Murphy K.C., Jones L., Buckland P.R., McGuffin P., Lesch K.P., Owen M.J. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol. Psychiatry. 3:1998;42-49.
55. Tan E.C., Chong S.A., Mahendran R., Dong F., Tan C.H. Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor. Biol. Psychiatry. 50:2001;144-147.
56. Tan E.C., Chong S.A., Chan A.O., Tan C.H. No evidence for association of the T102C polymorphism in the serotonin type 2A receptor with suicidal behavior in schizophrenia. Am. J. Med. Genet. 114:2002;321-322.
57. Tay A.H., Lim L.C., Lee W.L., Wong K.E., Wong L.Y., Tsoi W.F. Association between allele 1 of T102C polymorphism, 5-hydroxytryptamine 2a receptor gene and schizophrenia in Chinese males in Singapore. Hum. Hered. 47:1997;298-300.
58. Verga M., Macciardi F., Cohen S., Pedrini S., Smeraldi E. No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. Am. J. Med. Genet. 74:1997;21-25.
59. Virgos C., Martorell L., Valero J., Figuera L., Civeira F., Joven J., Labad A., Vilella E. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 49:2001;65-71.
60. Wang G.L., Moore M.L., McMillin J.B. A region in the first exon/intron of rat carnitine palmitoyltransferase Ibeta is involved in enhancement of basal transcription. Biochem. J. 362:2002;609-618.
61. Warren J.T. Jr., Peacock M.L., Rodriguez L.C., Fink J.K. An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum. Mol. Genet. 2:1993;338.
62. Watson R.E., Goodman J.I. Epigenetics and DNA methylation come of age in toxicology. Toxicol. Sci. 67:2002;11-16.
63. Williams J., Spurlock G., McGuffin P., Mallet J., Nothen M.M., Gill M., Aschauer H., Nylander P.O., Macciardi F., Owen M.J. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet. 347:1996;1294-1296.
64. Williams J., McGuffin P., Nothen M., Owen M.J. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet. 349:1997;1221.
65. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 19:1955;251-253.
66. Yoshihara E., Nakamura K., Itoh M., Ameno K., Takeuchi Y., Ijiri I., Iwahashi K. The human serotonin receptor gene (HTR2) MspI polymorphism in Japanese schizophrenic and alcoholic patients. Neuropsychobiology. 41:2000;124-126.
67. Yu Y.W., Tsai S.J., Yang K.H., Lin C.H., Chen M.C., Hong C.J. Evidence for an association between polymorphism in the serotonin-2A receptor variant (102T/C) and increment of N100 amplitude in schizophrenics treated with clozapine. Neuropsychobiology. 43:2001;79-82.